Details about Thomas Roediger-Schluga

Access statistics for papers by Thomas Roediger-Schluga.

Last updated 2021-05-11. Update your information in the RePEc Author Service.

Short-id: pro234

Working Papers

2007

1. R&D collaboration networks in the European FrameworkProgrammes: Data processing, network construction and selected results
   MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) View citations (26)

2006

2. Does technology affect network structure? - A quantitative analysis of collaborative research projects in two specific EU programmes
   MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) View citations (5)
3. The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
   MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) View citations (20)
   See also Journal Article The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan, Review of Industrial Organization, Springer (2006) View citations (20) (2006)
4. The structure of R&D collaboration networks in the European Framework Programmes
   MERIT Working Papers, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT) View citations (19)

2002

5. Some micro-evidence on the "Porter Hypothesis" from Austrian VOC emission standards
   ERSA conference papers, European Regional Science Association View citations (2)
   See also Journal Article Some Micro‐Evidence on the “Porter Hypothesis” from Austrian VOC Emission Standards, Growth and Change, Wiley Blackwell (2003) View citations (15) (2003)

2001

6. The Changing Nature of Pharmaceutical R&D - Opportunities for Asia?
   Research Memorandum, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT) View citations (1)

Journal Articles

2006

1. The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
   Review of Industrial Organization, 2006, 28, (2), 145-164 View citations (20)
   See also Working Paper The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan, MERIT Working Papers (2006) View citations (20) (2006)

2003

2. Some Micro‐Evidence on the “Porter Hypothesis” from Austrian VOC Emission Standards
   Growth and Change, 2003, 34, (3), 359-379 View citations (15)
   See also Working Paper Some micro-evidence on the "Porter Hypothesis" from Austrian VOC emission standards, ERSA conference papers (2002) View citations (2) (2002)

Books

2004

1. The Porter Hypothesis and the Economic Consequences of Environmental Regulation
   Books, Edward Elgar Publishing View citations (7)

Chapters

2007

1. Public-Private R&D Partnerships: Current Issues and Challenges
   Springer